Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-EN
Language English English
Date Updated 2023-03-21 2023-03-07
Drug Identification Number 00505005 00505005
Brand name FLUORESCITE FLUORESCITE
Common or Proper name FLUORESCEIN (FLUORESCEIN SODIUM) 10 % FLUORESCEIN (FLUORESCEIN SODIUM) 10 %
Company Name ALCON CANADA INC ALCON CANADA INC
Ingredients FLUORESCEIN FLUORESCEIN
Strength(s) 10% 10%
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5 ml 5 ml
ATC code V04CX V04CX
ATC description OTHER DIAGNOSTIC AGENTS OTHER DIAGNOSTIC AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-03-09 2023-03-09
Actual start date
Estimated end date 2023-03-31 2023-03-31
Actual end date 2023-03-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments